Back
ESC Premium Access

JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities

Session: Poster Session 7 - Genetics in cardiomyopathies
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor J. Koskenvuo (Turku, FI)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Juha Koskenvuo

Turku University Hospital, Turku (Finland)
0 follower

13 more presentations in this session

FHOD3 is a novel disease causing gene in hypertrophic cardiomyopathy

Speaker: Doctor J. Ochoa (A Coruna, ES)

Access
Abstract
Slides
Like
Thumbnail

Clinical presentation and outcomes in paediatric-onset hypertrophic cardiomyopathy associated with MYBPC3 mutations

Speaker: Miss E. Field (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Genotype phenotype relation in patients with hypertrophic cardiomyopathy: development of a model to predict the genetic yield

Speaker: Doctor T. Robyns (Leuven, BE)

Access
Abstract
Like
Thumbnail

Next generation sequencing in patients with hypertrophic cardiomyopathy

Speaker: Doctor J. Bonaventura (Prague, CZ)

Access
Abstract
Like
Thumbnail

Genetic spectrum of hypertrophic cardiomyopathy revisited. Whole Exome Sequencing reveals extreme genetic heterogeneity and new gene mutations in a multicenter series of 200 patients

Speaker: Doctor K. Nguyen (Marseille, FR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 7 - Genetics in cardiomyopathies

Speakers: Doctor J. Koskenvuo, Doctor J. Ochoa, Miss E. Field, Doctor T. Robyns, Doctor J. Bonaventura...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources